|
|
|
|
|
|
|
|
|
|
|
|
|
13.11.25 - 07:36
|
Bioretec Ltd′s business review January–September 2025: Strengthening commercial foundations and strategy design (Cision)
|
|
|
Bioretec Ltd Company release 13 November 2025 at 8.30 a.m. EET
T his announcement summarizes Bioretec Ltd's business review for January–September 2025. The complete business review is attached to this release as a PDF file and available on the company's website at https://investors.bioretec.com/en/reports_and_presentations.
July–September 2025 in brief
· Net sales amounted to EUR 715 thousand (7–9/2024: EUR 685 thousand).
· The sales margin (excl. other income) was EUR 441 (499) thousand, or 61.6% (72.9%) of net sales.
· EBITDA was EUR -1,768 (-1,353) thousand.
· The...
|
|
|
|
|
|
|
12.11.25 - 11:31
|
Inside information: Bioretec initiates change negotiations to enance operational efficiency and competitiveness (Cision)
|
|
|
Bioretec Ltd Inside information 12 November 2025 at 12.30 p.m. EET
Bioretec Ltd is initiating change negotiations in accordance with the Finnish Act on Co-operation within Undertakings. The aim of the negotiations is to streamline and reorganize operations in order to improve the company's competitiveness and profitability. The negotiations will focus on Bioretec's production and marketing functions in Finland.
The change negotiations will commence on 19 November 2025 and will last for an estimated 2 weeks.
A total of 15 employees from Bioretec's staff in Finland are included in the...
|
|
|
|
|
|
|
06.11.25 - 08:06
|
Optomed Plc: Interim Report, January – September 2025 (Cision)
|
|
|
Optomed PlcStock Exchange Release 6 November 2025 at 9.00, Helsinki
Optomed Plc: Interim Report, January – September 2025
July– September 2025
· Revenue increased by 42.1 percent to EUR 4.4 (3.1) million.
· Currency-adjusted revenue growth was 47.0 percent.
· Devices segment revenue increased by 183.6 percent to EUR 2.3 (0.8) million.
· Devices segment currency-adjusted revenue growth was 202.5 percent.
· Software segment revenue decreased by 8.0 percent to EUR 2.1 (2.3) million.
· EBITDA amounted to EUR -0.5 (-0.8) million corresponding to -12.1 (-26.2)...
|
|
|
05.11.25 - 15:01
|
Pihlajalinna Plc: Managers′ transactions (Cision)
|
|
|
Pihlajalinna Plc Managers' transactions 5 November 2025 at 4:00 p.m. EET
Pihlajalinna Plc: Managers' transactions
Pihlajalinna Plc has received the following notification on 5 November 2025:
Person subject to the notification requirement
Name: SSK Sijoitus Oy
Position: Chief Executive Officer
(X) Legal person (1): Person Discharging Managerial Responsibilities In Issuer
Name: Seppo Kariniemi
Position: Other senior manager
Issuer: Pihlajalinna Oyj
LEI: 74370058MTRLEDOCHV67
Notification type: INITIAL NOTIFICATION
Reference number: 129313/6/6
____________________...
|
|
|
04.11.25 - 15:18
|
Pihlajalinna Plc: Managers′ transactions (Cision)
|
|
|
Pihlajalinna Plc Managers' transactions 4 November 2025 at 4:15 p.m. EET
Pihlajalinna Plc: Managers' transactions
Pihlajalinna Plc has received the following notification on 4 November 2025:
Person subject to the notification requirement
Name: Videman Renewal Oy
Position: Chief Executive Officer
(X) Legal person (1): Person Discharging Managerial Responsibilities In Issuer
Name: Mika Anders Videman
Position: Other senior manager
Issuer: Pihlajalinna Oyj
LEI: 74370058MTRLEDOCHV67
Notification type: INITIAL NOTIFICATION
Reference number: 129164/5/4
___________...
|
|
|
|
|
|
|
31.10.25 - 08:03
|
Correction: Bioretec Ltd′s Half-year report 2025 (PR Newswire)
|
|
|
Bioretec Ltd Company release 31 October 2025 at 8.30 a.m. EET TAMPERE, Finland, Oct. 31, 2025 /PRNewswire/ -- Bioretec announced on 27 October 2025 that it will adjust and restate its previously reported figures for H1/2025. The adjustment and restatement is related to the sales and......
|
|
|
31.10.25 - 07:36
|
Inside Information: Pihlajalinna′s new operating model and appointment of the Management Team (Cision)
|
|
|
Pihlajalinna Plc Inside Information 31 October 2025 at 8:30 a.m. EET
Inside Information: Pihlajalinna's new operating model and appointment of the Management Team
Pihlajalinna Plc's new operating model and the corresponding Management Team have been confirmed. The new operating model ensures development and growth in line with Pihlajalinna's strategy and responds to business transformation. The new operating model and Management Team will be effective 1 Januray 2026.
The new operating model consists of health services, medical leadership, commercial operations and group...
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
